Arovella Therapeutics (ASX:ALA) has strengthened its Board with the appointment of Dr Andrew Nash, the former Chief Scientific Officer of CSL, as a Non-Executive Director, effective 12 November 2025. …
Arovella appoints former CSL Chief Scientific Officer Dr Andrew Nash to its Board
November 12, 2025 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
Australians turn to local pharmacies as frontline of everyday healthcare
March 13, 2026 - - Latest News -
Sandoz and Camp Quality unite to strengthen support for Australian families facing childhood cancer
March 13, 2026 - - Latest News -
The leadership challenge behind Australia’s medicine access gap
March 13, 2026 - - Latest News -
Australia has spent four decades having the wrong conversation about medicines access
March 13, 2026 - - Latest News -
‘An absolute medical miracle’ - MPs highlight progress and challenges at Cystic Fibrosis event
March 13, 2026 - - Latest News -
Australia’s top community pharmacists honoured at national awards
March 13, 2026 - - Latest News -
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - - Australian Biotech